Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
NCT ID: NCT02707653
Last Updated: 2018-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2016-03-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Misoprostol for the Treatment of Incomplete Abortion
NCT00670761
A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion
NCT02708446
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985
Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment
NCT00674232
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
NCT00466999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Miso
Misoprostol 400 s/l
Misoprostol
400 mcg sublingual misoprostol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
400 mcg sublingual misoprostol
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No known contraindications to the study drug
3. Uterine size no larger than 12 weeks at time of presentation for care
4. No signs of severe infection, defined as at least two of the following:
* foul smelling discharge,
* fever \> 38 degrees C, 100 degrees Fahrenheit
* uterine tenderness.
5. No hemodynamic disturbances (pulse \>110/min and systolic bp \<100)
6. General good health
7. Agree to comply with study procedures including return for follow up visit
8. Live or work within one hour from a study site
9. Willing and able to sign consent forms
Exclusion Criteria
12 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Medical Research, Lower Myanmar
OTHER
Gynuity Health Projects
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Woman's Hospital
Yangon, , Burma
Thingyan Sanpya Hospital
Yangon, , Burma
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.